Literature DB >> 32266461

Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense-Birmingham definition.

Max Rohde1,2, Tine Rosenberg3,4, Manan Pareek5, Paul Nankivell6, Neil Sharma6, Hisham Mehanna6, Christian Godballe3,4.   

Abstract

PURPOSE: The objectives of this study were (1) to systematically review current definitions of head and neck squamous cell carcinoma (HNSCC) recurrence and (2) to propose a definition of locally recurrent HNSCC.
METHODS: A systematic literature review was performed according to the 'Preferred Reporting Items for Systematic Reviews and Meta-Analyses' statement in Medline, Embase, and Cochrane databases guided by the study question "What is the definition of local recurrence for patients with HN:SCC?". All retrieved studies were reviewed and qualitatively analyzed.
RESULTS: The systematic literature search resulted in 3467 publications after removal of duplicates. Forty studies were examined as full text, and a total of five were found suitable for inclusion. All five included studies dealt with definitions of second primary HNSCC and were based on the Warren and Gates Criteria; (1) each of the tumors are malignant, (2) each must be distinct, and (3) the probability of one being a metastasis of the other must be excluded. Each of the included studies added specific anatomical and/or temporal separation measures to the criteria of second primary HNSCC. We propose the definition of locally recurrent HNSCC to be: (1) Same anatomical subsite or adjacent subsite within 3 cm of the primary lesion, (2) time-interval no more than 3 years (from completed treatment of the primary lesion), and (3) same p16-status for oropharyngeal carcinomas.
CONCLUSIONS: No uniform definition of locally recurrent HNSCC currently exists. We propose the Odense-Birmingham definition based on the anatomical subsite combined with a specific measurable distance and a temporal separation of three years.

Entities:  

Keywords:  Definition; Head and neck neoplasms; Recurrence; Relapse

Mesh:

Year:  2020        PMID: 32266461     DOI: 10.1007/s00405-020-05953-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.

Authors:  Max Rohde; Anne L Nielsen; Jørgen Johansen; Jens A Sørensen; Anabel Diaz; Manan Pareek; Jon T Asmussen; Oke Gerke; Anders Thomassen; Niels Gyldenkerne; Helle Døssing; Kristine Bjørndal; Poul Flemming Høilund-Carlsen; Christian Godballe
Journal:  Oral Oncol       Date:  2019-05-06       Impact factor: 5.337

2.  FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.

Authors:  Yuko Suenaga; Kazuhiro Kitajima; Takeaki Ishihara; Ryohei Sasaki; Naoki Otsuki; Ken-Ichi Nibu; Tsutomu Minamikawa; Naomi Kiyota; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

3.  Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.

Authors:  K K Ang; A Trotti; B W Brown; A S Garden; R L Foote; W H Morrison; F B Geara; D W Klotch; H Goepfert; L J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

4.  Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours.

Authors:  B Bittorf; H Kessler; S Merkel; W Brückl; A Wein; W G Ballhausen; W Hohenberger; K Günther
Journal:  Eur J Surg Oncol       Date:  2001-04       Impact factor: 4.424

5.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors:  W K Hong; S M Lippman; L M Itri; D D Karp; J S Lee; R M Byers; S P Schantz; A M Kramer; R Lotan; L J Peters
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

7.  Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer.

Authors:  Max Rohde; Anne L Nielsen; Jørgen Johansen; Jens A Sørensen; Nina Nguyen; Anabel Diaz; Mie K Nielsen; Jon T Asmussen; Janus M Christiansen; Oke Gerke; Anders Thomassen; Abass Alavi; Poul Flemming Høilund-Carlsen; Christian Godballe
Journal:  J Nucl Med       Date:  2017-06-01       Impact factor: 10.057

8.  Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  H Mehanna; A Kong; S K Ahmed
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21

10.  Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes.

Authors:  Jer-Hwa Chang; Chia-Che Wu; Kevin Sheng-Po Yuan; Alexander T H Wu; Szu-Yuan Wu
Journal:  Oncotarget       Date:  2017-03-17
View more
  1 in total

1.  Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors:  Yue He; Zhonglong Liu; Surui Sheng; Weijin Gao; Xiao Tang; Xiaoguang Li; Chunyue Ma
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.